News About: Pharm. Affairs
The Korea Pharmaceutical Association opposed on the extensive policy about the animal medicine manager
As an opinion brought up to add veterinarians and medical technologists as wholesale managers dealing with animal medicines, the Korean Pharmaceutical Associationdecided to strongly oppose to the opinion.
The Korean ...
‘Prevenar13’ and ‘Synflorix’have enjoyed the effect of the NIP
As pneumococcus vaccines for infants became free last May, the number of vaccination under the National Immunization Program (NIP)has significantly increased.
According to the institutions concerned, such as the Kore...
A new Alzheimer type dementia diagnostic treatment has been approved in Korea, the first time in Asia
After the FDA in the U.S. and the EMA in Europe, a new Alzheimer type dementia treatment has been permitted by the Ministry of Food and Drug Safety for the third time.
The new drug, titled ‘Nuraceq (Flobetaben F18)’,...
Zantac 75mg will be out of stock until February 2015.. Is this an effect of advertisements?Zantac Tab 75 mg will not be supplied until February2015.
GSK, recently, made a notice in its webpage regarding its out-of-stock-indefinitely, and asked pharmaceutical distribu...
|
The U.S. Court dismissed the Celltrion’s claim to nullify the patent of Ramicade
The U.S. Court dismissed the patent nullity action for the rheumatoid arthritis treatment ‘Remicade’, which was filed by Celltrion.
According to the industry concerned on the 7th, the U.S. court made a judgment to di...
Things that will change if identifier codes of pharmaceutical products are applied
Ifthe identifier coderegulation on pharmaceutical products is actively enforced, it seems that pharmaceutical distribution companies should have a different way to report supply transactions to the existing one.
Rece...
It has been 5 years since the launch of ‘Herceptin’… a targeted agent for stomach cancer will come outIt is expected that a new targeted agent will be launched since the launch of ‘Herceptin’ 5 years ago.
According to the industry concerned on the 28th, Lilly Korea is following...
|
Generic products having at most 15% lower price than the originals
Pharmaceutical companies’ strategies to register prices of generic products lower than the originals seem to settle in the pharmaceutical industry. Among the 10 newly registered products on the 1stof the next month, o...
Sanofi Pasteur is allowed to sell ‘Menactra’ in KoreaSanofi Pasteur (president Regis Launay) announced that ‘Menactra’, a meningococcal (Groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine, receivedmarketi...
|
The 73.1% pharmacist license users in Korea are working in pharmacies
It is known that 41.8% of the entire pharmacist license owners and 73.1% of the currentlicense users are working in pharmacies.
Go-eun Lee, deputy director of the Pharmaceutical Policy Division, the Ministry of Healt...
